These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6408728)

  • 1. Pituitary function in 20 cases of prolactinoma in females.
    Eşanu C; Klepsch I; Calciu G; Bucur D; Popescu LG
    Endocrinologie; 1983; 21(2):131-9. PubMed ID: 6408728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells.
    Werner S
    Horm Metab Res; 1979 Jul; 11(7):452-3. PubMed ID: 113330
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin antagonist-induced lowering of prolactin secretion does not affect the pattern of pulsatile secretion of follicle-stimulating hormone and luteinizing hormone in the bitch.
    Beijerink NJ; Kooistra HS; Dieleman SJ; Okkens AC
    Reproduction; 2004 Aug; 128(2):181-8. PubMed ID: 15280557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
    Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH
    Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reaction of human pituitary prolactinoma cells to TRH and dopamine in vitro].
    Tong J
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):649-51. PubMed ID: 1963362
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D; Malarkey WB
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of prolactin secretion in canine pituitary-dependent hyperadrenocorticism.
    Stolp R; Bevers MM; Rijnberk A; Croughs RJ; Rutteman GR
    Horm Metab Res; 1986 Sep; 18(9):595-8. PubMed ID: 3096858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
    Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
    J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
    de Quijada M; Timmermans HA; Lamberts SW; MacLeod RM
    Endocrinology; 1980 Mar; 106(3):702-6. PubMed ID: 6766385
    [No Abstract]   [Full Text] [Related]  

  • 10. Inter-relationships between the secretory dynamics of thyrotrophin-releasing hormone, thyrotrophin and prolactin in periovulatory mares: effect of hypothyroidism.
    Alexander SL; Irvine CH; Evans MJ
    J Neuroendocrinol; 2004 Nov; 16(11):906-15. PubMed ID: 15584931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA; Esquifino AI
    Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and gonadal function.
    Besser GM; Thorner MO
    Pathol Biol (Paris); 1975 Dec; 23(10):779-82. PubMed ID: 817251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
    Richards GE; Holland FJ; Aubert ML; Ganong WF; Kaplan SL; Grumbach MM
    Neuroendocrinology; 1980; 30(3):139-43. PubMed ID: 6767993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP; Carmel PW; Frantz AG; Ferin M
    J Clin Endocrinol Metab; 1976 Sep; 43(3):638-42. PubMed ID: 821963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
    Peillon F; Cesselin F; Zygelman N; Brandi A; Mauborgne A
    Ann Endocrinol (Paris); 1978; 39(3):255-7. PubMed ID: 718128
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions of steroids with prolactin secretion in vitro.
    Lamberts SW
    Horm Res; 1985; 22(3):172-8. PubMed ID: 4054837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-DOPA and the control of prolactin secretion.
    Frantz AG; Suh HK
    Adv Neurol; 1974; 5():447-56. PubMed ID: 4216257
    [No Abstract]   [Full Text] [Related]  

  • 18. [Validity of radioimmunoassay for blood and pituitary prolactin in the male rat. Effect of bromocriptine and thyrotropin-releasing hormone].
    André M; Grizard G; Boucher D
    C R Seances Soc Biol Fil; 1981; 175(6):792-800. PubMed ID: 6459824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolactin on the luteinizing hormone response to gonadotropin- releasing hormone in primary pituitary cell cultures during the ovine annual reproductive cycle.
    Gregory SJ; Townsend J; McNeilly AS; Tortonese DJ
    Biol Reprod; 2004 May; 70(5):1299-305. PubMed ID: 14695904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.